BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Condat B, Pessione F, Hillaire S, Denninger MH, Guillin MC, Poliquin M, Hadengue A, Erlinger S, Valla D. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology. 2001;120:490-497. [PMID: 11159889 DOI: 10.1053/gast.2001.21209] [Cited by in Crossref: 322] [Cited by in F6Publishing: 252] [Article Influence: 16.1] [Reference Citation Analysis]
Number Citing Articles
1 Francque S, Condat B, Asselah T, Vilgrain V, Durand F, Moreau R, Valla D. Multifactorial aetiology of hepatic infarction: a case report with literature review. Eur J Gastroenterol Hepatol. 2004;16:411-415. [PMID: 15028975 DOI: 10.1097/00042737-200404000-00008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zumberg M, Kitchens CS. Venous Thromboses at Unusual Sites. Consultative Hemostasis and Thrombosis. Elsevier; 2007. pp. 257-80. [DOI: 10.1016/b978-141602401-9.10016-1] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
3 Kalambokis G, Svarna E, Tsianos EV. Long-term anticoagulation therapy for a cirrhotic patient with recurrent deep venous thrombosis. J Gastroenterol Hepatol 2005;20:1803-4. [PMID: 16246210 DOI: 10.1111/j.1440-1746.2005.04044.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Ponziani FR, Zocco MA, Senzolo M, Pompili M, Gasbarrini A, Avolio AW. Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up. Transplant Rev (Orlando). 2014;28:92-101. [PMID: 24582320 DOI: 10.1016/j.trre.2014.01.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
5 Regnault H, Emambux S, Lecomte T, Doat S, Dhooge M, Besson M, Dubreuil O, Moryoussef F, Silvain C, Bachet JB, Tougeron D. Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study. Dig Liver Dis 2018;50:285-90. [PMID: 29183764 DOI: 10.1016/j.dld.2017.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Pinto RB, Silveira TR, Bandinelli E, Röhsig L. Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders. J Pediatr Surg 2004;39:1356-61. [PMID: 15359390 DOI: 10.1016/j.jpedsurg.2004.05.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
7 Spahr L, Boehlen F, de Moerloose P, Hadengue A. Anticoagulants in portal vein thrombosis: don't be so shy! Blood. 2009;113:5031-5032; author reply 5032. [PMID: 19443675 DOI: 10.1182/blood-2009-02-202770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Radovanovic N, Dumic I, Veselinovic M, Burger S, Milovanovic T, Nordstrom CW, Niendorf E, Ramanan P. Fusobacterium necrophorum subsp. necrophorum Liver Abscess with Pylephlebitis: An Abdominal Variant of Lemierre's Syndrome. Case Rep Infect Dis 2020;2020:9237267. [PMID: 31993242 DOI: 10.1155/2020/9237267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis. 2017;49:113-120. [PMID: 27965037 DOI: 10.1016/j.dld.2016.11.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
10 Villa E, Cammà C, Marietta M, Luongo M, Critelli R, Colopi S, Tata C, Zecchini R, Gitto S, Petta S, Lei B, Bernabucci V, Vukotic R, De Maria N, Schepis F, Karampatou A, Caporali C, Simoni L, Del Buono M, Zambotto B, Turola E, Fornaciari G, Schianchi S, Ferrari A, Valla D. Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis. Gastroenterology 2012;143:1253-1260.e4. [DOI: 10.1053/j.gastro.2012.07.018] [Cited by in Crossref: 418] [Cited by in F6Publishing: 311] [Article Influence: 46.4] [Reference Citation Analysis]
11 Valla DC, Cazals-Hatem D. Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts. Virchows Arch. 2018;473:3-13. [PMID: 29572606 DOI: 10.1007/s00428-018-2331-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Finazzi G, Barbui T. How I treat patients with polycythemia vera. Blood 2007;109:5104-11. [PMID: 17264301 DOI: 10.1182/blood-2006-12-038968] [Cited by in Crossref: 76] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
13 Gong C, Qin X, Yang J, Guo T. The Best Anticoagulation Strategy for Cirrhotic Patients who Underwent Splenectomy: A Network Meta-Analysis. Gastroenterol Res Pract 2017;2017:9216172. [PMID: 28676822 DOI: 10.1155/2017/9216172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wobser H, Schölmerich J, Büttner R. [19-year-old kick-boxer with hematemesis and splenomegaly]. Internist (Berl) 2010;51:213-8. [PMID: 19771406 DOI: 10.1007/s00108-009-2446-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Kawanaka H, Akahoshi T, Kinjo N, Konishi K, Yoshida D, Anegawa G, Yamaguchi S, Uehara H, Hashimoto N, Tsutsumi N. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg. 2010;251:76-83. [PMID: 19864937 DOI: 10.1097/sla.0b013e3181bdf8ad] [Cited by in Crossref: 79] [Cited by in F6Publishing: 28] [Article Influence: 7.2] [Reference Citation Analysis]
16 Gioia S, Nardelli S, Pasquale C, Pentassuglio I, Nicoletti V, Aprile F, Merli M, Riggio O. Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis. Dig Liver Dis. 2018;50:839-844. [PMID: 29429910 DOI: 10.1016/j.dld.2018.01.132] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
17 Senzolo M, Rodriguez K, Nadal E, Burra P. Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension (Br J Surg 2010; 97: 910-916). Br J Surg. 2010;97:1452; author reply 1452-1453. [PMID: 20683871 DOI: 10.1002/bjs.7002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
18 Riva N, Ageno W, Poli D, Testa S, Rupoli S, Santoro R, Lerede T, Piana A, Carpenedo M, Nicolini A, Ferrini PM, Tosetto A; the Italian Federation of Anticoagulation Clinics (FCSA). Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study. J Thromb Haemost 2015;13:1019-27. [DOI: 10.1111/jth.12930] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
19 Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol. 2007;13:2535-2540. [PMID: 17552000 DOI: 10.3748/wjq.v13.i18.2535] [Reference Citation Analysis]
20 Kumar A, Sharma P, Arora A. Review article: portal vein obstruction - epidemiology, pathogenesis, natural history, prognosis and treatment. Aliment Pharmacol Ther 2015;41:276-92. [DOI: 10.1111/apt.13019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 5.9] [Reference Citation Analysis]
21 Morita H, Nishiwaki H, Nagayama Y, Yoshimura A. Portal vein thrombosis in adult-onset Still’s disease: a case report and literature review. Rheumatol Int 2009;29:1515-8. [DOI: 10.1007/s00296-009-0894-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
22 Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP. Hypercoagulability and Hypofibrinolysis and Risk of Deep Vein Thrombosis and Splanchnic Vein Thrombosis: Similarities and Differences. Arterioscler Thromb Vasc Biol 2011;31:485-93. [DOI: 10.1161/atvbaha.110.213371] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
23 Lin HY, Ho CM, Lai HS, Lee PH. Management of acute portomesenteric venous thrombosis induced by protein S deficiency: report of a case. Surg Today. 2012;42:1014-1018. [PMID: 22484987 DOI: 10.1007/s00595-012-0176-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Hayashi T, Takatori H, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Kitamura K, Kawaguchi K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Toyama T, Okumura K, Kozaka K, Kaneko S. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients. BMC Gastroenterol 2019;19:217. [PMID: 31842768 DOI: 10.1186/s12876-019-1140-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
25 Duceppe E, Lauzon JF, Galliger S, Zhang B, Solomon H, Serrano PE. Incidence and predictors of splanchnic vein thrombosis and mortality following hepatobiliary and pancreatic surgery. J Thromb Haemost 2021;19:797-804. [PMID: 33249718 DOI: 10.1111/jth.15198] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Thalheimer U, Bosch J, Burroughs AK. How to prevent varices from bleeding: shades of grey--the case for nonselective beta blockers. Gastroenterology. 2007;133:2029-2036. [PMID: 18054573 DOI: 10.1053/j.gastro.2007.10.028] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 4.6] [Reference Citation Analysis]
27 Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S-e496S. [PMID: 22315268 DOI: 10.1378/chest.11-2301] [Cited by in Crossref: 2185] [Cited by in F6Publishing: 1606] [Article Influence: 242.8] [Reference Citation Analysis]
28 Chen Q, Tack C, Morcos M, Ruggiero M, Schlossberg P, Fogel J, Weng LJ, Farkas J. Embolotherapy of an arterioportal fistula. Cardiovasc Intervent Radiol. 2007;30:1047-1051. [PMID: 17497067 DOI: 10.1007/s00270-007-9041-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
29 Fimognari FL, Violi F. Portal vein thrombosis in liver cirrhosis. Intern Emerg Med. 2008;3:213-218. [PMID: 18274708 DOI: 10.1007/s11739-008-0128-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
30 Sun SL, Wang XY, Chu CN, Liu BC, Li QR, Ding WW. Predictors of irreversible intestinal resection in patients with acute mesenteric venous thrombosis. World J Gastroenterol 2020;26:3625-37. [PMID: 32742131 DOI: 10.3748/wjg.v26.i25.3625] [Reference Citation Analysis]
31 Amitrano L, Guardascione MA, Scaglione M, Pezzullo L, Sangiuliano N, Armellino MF, Manguso F, Margaglione M, Ames PR, Iannaccone L, Grandone E, Romano L, Balzano A. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol. 2007;102:2464-2470. [PMID: 17958760 DOI: 10.1111/j.1572-0241.2007.01477.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 136] [Article Influence: 13.8] [Reference Citation Analysis]
32 Naymagon L. Venous thrombosis of the liver: current and emerging concepts in management. Transl Res 2020;225:54-69. [PMID: 32407789 DOI: 10.1016/j.trsl.2020.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
33 Barbui T, Finazzi G. Special issues in myeloproliferative neoplasms. Curr Hematol Malig Rep 2011;6:28-35. [PMID: 21181458 DOI: 10.1007/s11899-010-0073-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
34 Hambleton J, Leung LL, Levi M. Coagulation: Consultative Hemostasis. Hematology 2002;2002:335-52. [DOI: 10.1182/asheducation-2002.1.335] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
35 Thatipelli MR, McBane RD, Hodge DO, Wysokinski WE. Survival and recurrence in patients with splanchnic vein thromboses. Clin Gastroenterol Hepatol. 2010;8:200-205. [PMID: 19782767 DOI: 10.1016/j.cgh.2009.09.019] [Cited by in Crossref: 112] [Cited by in F6Publishing: 90] [Article Influence: 9.3] [Reference Citation Analysis]
36 Bajaj JS, Franco J. Endoscopic band ligation of esophageal varices in patients on anticoagulation. J Clin Gastroenterol. 2008;42:782-785. [PMID: 18668702 DOI: 10.1097/mcg.0b013e31804bb98b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
37 Finazzi G, De Stefano V, Barbui T. Are MPNs vascular diseases? Curr Hematol Malig Rep 2013;8:307-16. [PMID: 24037420 DOI: 10.1007/s11899-013-0176-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
38 Björck M, Koelemay M, Acosta S, Bastos Goncalves F, Kölbel T, Kolkman JJ, Lees T, Lefevre JH, Menyhei G, Oderich G, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfe N, Debus S, Hinchliffe R, Kakkos S, Koncar I, Sanddal Lindholt J, Vega de Ceniga M, Vermassen F, Verzini F, Document Reviewers, Geelkerken B, Gloviczki P, Huber T, Naylor R. Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017;53:460-510. [PMID: 28359440 DOI: 10.1016/j.ejvs.2017.01.010] [Cited by in Crossref: 190] [Cited by in F6Publishing: 131] [Article Influence: 63.3] [Reference Citation Analysis]
39 Rottenstreich A, Khalaileh A, Elazary R. Sleeve gastrectomy and mesenteric venous thrombosis: report of 3 patients and review of the literature. Surgery for Obesity and Related Diseases 2014;10:e57-61. [DOI: 10.1016/j.soard.2014.07.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
40 Turnes J, García–pagán JC, González M, Aracil C, Calleja JL, Ripoll C, Abraldeṣ JG, Bañares R, Villanueva C, Albillos A, Ayuso JR, Gilabert R, Bosch J. Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation. Clinical Gastroenterology and Hepatology 2008;6:1412-7. [DOI: 10.1016/j.cgh.2008.07.031] [Cited by in Crossref: 113] [Cited by in F6Publishing: 76] [Article Influence: 8.7] [Reference Citation Analysis]
41 Amarapurkar P, Bhatt N, Patel N, Amarapurkar D. Primary extrahepatic portal vein obstruction in adults: A single center experience. Indian J Gastroenterol 2014;33:19-22. [DOI: 10.1007/s12664-013-0368-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
42 Amitrano L, Guardascione MA, Brancaccio V, Iannaccone L, Ames PR, Balzano A. Portal and mesenteric venous thrombosis in cirrhotic patients. Gastroenterology 2002;123:1409-10. [DOI: 10.1053/gast.2002.36391] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
43 Ageno W. Managing unusual presentations of venous thromboembolism. J Thromb Thrombolysis 2015;39:304-10. [DOI: 10.1007/s11239-015-1171-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chait Y, Condat B, Cazals-Hatem D, Rufat P, Atmani S, Chaoui D, Guilmin F, Kiladjian JJ, Plessier A, Denninger MH. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. Br J Haematol. 2005;129:553-560. [PMID: 15877740 DOI: 10.1111/j.1365-2141.2005.05490.x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 78] [Article Influence: 6.9] [Reference Citation Analysis]
45 Qi X, He C, Han G, Yin Z, Wu F, Zhang Q, Niu J, Wu K, Fan D. Prevalence of paroxysmal nocturnal hemoglobinuria in Chinese patients with Budd-Chiari syndrome or portal vein thrombosis. J Gastroenterol Hepatol 2013;28:148-52. [PMID: 23020629 DOI: 10.1111/j.1440-1746.2012.07282.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
46 Ageno W, Dentali F, Pomero F, Fenoglio L, Squizzato A, Pagani G, Re R, Bonzini M. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. ThrombHaemost. 2017;117:794-800. [PMID: 28180235 DOI: 10.1160/th16-10-0781] [Cited by in Crossref: 39] [Cited by in F6Publishing: 10] [Article Influence: 9.8] [Reference Citation Analysis]
47 Appelmann I, Kreher S, Parmentier S, Wolf HH, Bisping G, Kirschner M, Bergmann F, Schilling K, Brümmendorf TH, Petrides PE, Tiede A, Matzdorff A, Griesshammer M, Riess H, Koschmieder S. Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH). Ann Hematol 2016;95:707-18. [PMID: 26916570 DOI: 10.1007/s00277-016-2621-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
48 Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013;58:1776-1780. [PMID: 23314858 DOI: 10.1007/s10620-012-2548-y] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 11.1] [Reference Citation Analysis]
49 Cohen R, Mallet T, Gale M, Soltys R, Loarte P. Portal vein thrombosis. Case Rep Vasc Med 2015;2015:823063. [PMID: 25802795 DOI: 10.1155/2015/823063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut. 2005;54:691-697. [PMID: 15831918 DOI: 10.1136/gut.2004.042796]] [Reference Citation Analysis]
51 Zhou H, Xuan J, Lin X, Guo Y. Recurrent esophagogastric variceal bleeding due to portal vein thrombosis caused by protein S deficiency. Endosc Int Open 2018;6:E1283-8. [PMID: 30410946 DOI: 10.1055/a-0684-9638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
52 De Stefano V, Martinelli I. Abdominal thromboses of splanchnic, renal and ovarian veins. Best Pract Res Clin Haematol 2012;25:253-64. [PMID: 22959542 DOI: 10.1016/j.beha.2012.07.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
53 Bissonnette J, Durand F, de Raucourt E, Ceccaldi PF, Plessier A, Valla D, Rautou PE. Pregnancy and vascular liver disease. J Clin Exp Hepatol 2015;5:41-50. [PMID: 25941432 DOI: 10.1016/j.jceh.2014.12.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
54 Pasmant E, de Beauvoir C, Plessier A, Labreuche J, Bezeaud A. VKORC1 and CYP2C9 genetic polymorphisms in hepatic or portal vein thrombosis. Thrombosis Research 2010;126:e134-6. [DOI: 10.1016/j.thromres.2010.03.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
55 Donadini MP, Ageno W. Unusual site thrombosis. Semin Hematol 2011;48:264-70. [PMID: 22000092 DOI: 10.1053/j.seminhematol.2011.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
56 Cho CW, Park YJ, Kim YW, Choi SH, Heo JS, Choi DW, Kim DI. Follow-up results of acute portal and splenic vein thrombosis with or without anticoagulation therapy after hepatobiliary and pancreatic surgery. Ann Surg Treat Res. 2015;88:208-214. [PMID: 25844355 DOI: 10.4174/astr.2015.88.4.208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
57 Spanier BW, Frederiks J. Aetiology of extrahepatic portal vein thrombosis. Gut. 2002;51:755-756; author reply 756. [PMID: 12377821 DOI: 10.1136/gut.51.5.755-b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
58 Vibert É, Azoulay D, Castaing D, Bismuth H. Le cavernome portal : diagnostic, étiologies et conséquences. Annales de Chirurgie 2002;127:745-50. [DOI: 10.1016/s0003-3944(02)00897-0] [Cited by in Crossref: 13] [Article Influence: 0.7] [Reference Citation Analysis]
59 Valla D, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the West: Portal vein thrombosis in the West. Journal of Gastroenterology and Hepatology 2002;17:S224-7. [DOI: 10.1046/j.1440-1746.17.s3.4.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
60 Guillaume M, Christol C, Plessier A, Corbic M, Péron J, Sommet A, Rautou P, Consigny Y, Vinel J, Valla C, Bureau C. Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation: . European Journal of Gastroenterology & Hepatology 2018;30:563-8. [DOI: 10.1097/meg.0000000000001061] [Cited by in Crossref: 9] [Article Influence: 3.0] [Reference Citation Analysis]
61 Qi X. Portal Vein Thrombosis: Recent Advance. Adv Exp Med Biol. 2017;906:229-239. [PMID: 27638623 DOI: 10.1007/5584_2016_118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
62 Rosenberg JM, Tedesco M, Yao DC, Eisenberg D. Portal vein thrombosis following laparoscopic sleeve gastrectomy for morbid obesity. JSLS 2012;16:639-43. [PMID: 23484577 DOI: 10.4293/108680812X13517013316636] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 3.9] [Reference Citation Analysis]
63 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
64 Plompen EP, Schouten JN, Janssen HL. Role of anticoagulant therapy in liver disease. Hepatol Int. 2013;7:369-376. [PMID: 26201771 DOI: 10.1007/s12072-013-9427-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
65 Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736-741. [PMID: 15094219 DOI: 10.1016/j.jhep.2004.01.001] [Cited by in Crossref: 362] [Cited by in F6Publishing: 279] [Article Influence: 21.3] [Reference Citation Analysis]
66 Spaander MCW, Van Buuren HR, Hansen BE, Janssen HLA. Ascites in patients with noncirrhotic nonmalignant extrahepatic portal vein thrombosis: Ascites in patients with portal vein thrombosis. Alimentary Pharmacology & Therapeutics 2010;32:529-34. [DOI: 10.1111/j.1365-2036.2010.04375.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
67 Harki J, Sana A, van Noord D, van Diest PJ, van der Groep P, Kuipers EJ, Moons LMG, Biermann K, Tjwa ETTL. Hypoxia-inducible factor 1-α in chronic gastrointestinal ischemia. Virchows Arch 2015;466:125-32. [DOI: 10.1007/s00428-014-1691-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
68 Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W. Clinical approach to splanchnic vein thrombosis: risk factors and treatment. Thromb Res. 2012;130 Suppl 1:S1-S3. [PMID: 23026649 DOI: 10.1016/j.thromres.2012.08.259] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
69 Molina-infante J, Sanz-garcía C, Catalina-rodríguez M, Nogales-rincón O, Matilla-peña A, Núñez-martínez O, Clemente-ricote G. Trombosis venosa masiva abdominal con insuficiencia hepática aguda y megacolon tóxico como presentación de colitis ulcerosa. Gastroenterología y Hepatología 2005;28:551-4. [DOI: 10.1157/13080608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
70 Tufano A, Ageno W, Di Micco P, Niglio A, Rosa V, Ballaz A, Braester A, Rubio CM, Isern V, Imbalzano E, Monreal M. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis. Thrombosis Research 2018;164:69-74. [DOI: 10.1016/j.thromres.2018.02.143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
71 Orr DW, Harrison PM, Devlin J, Karani JB, Kane PA, Heaton ND, O'Grady JG, Heneghan MA. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol 2007;5:80-6. [PMID: 17142105 DOI: 10.1016/j.cgh.2006.09.030] [Cited by in Crossref: 65] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
72 Lim HQC, Lee XWJ, Mathias N. A Rare Finding of Falciform Ligament Thrombosis as a Sequel of Acute Pancreatitis. Case Rep Radiol 2017;2017:2879568. [PMID: 29403671 DOI: 10.1155/2017/2879568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Priyanka P, Kupec JT, Krafft M, Shah NA, Reynolds GJ. Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis. Int J Hepatol. 2018;2018:8432781. [PMID: 29973997 DOI: 10.1155/2018/8432781] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
74 Gupta S, Hidalgo J, Singh B, Iyer A, Yang Y, Short A, Singh S, Bhatt H, Gupta S. Usage of Direct Acting Oral Anticoagulants in Cirrhotic and Non-Cirrhotic Portal Vein Thrombosis: A Systematic Review. Cureus 2021;13:e16922. [PMID: 34367844 DOI: 10.7759/cureus.16922] [Reference Citation Analysis]
75 Soyuncu S, Cete Y, Nokay AE. Portal vein thrombosis related to Cassia angustifolia. Clin Toxicol (Phila). 2008;46:774-777. [PMID: 19238740 DOI: 10.1080/15563650701682097] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
76 Gioia S, Nardelli S, Ridola L, Riggio O. Causes and Management of Non-cirrhotic Portal Hypertension​. Curr Gastroenterol Rep 2020;22:56. [PMID: 32940785 DOI: 10.1007/s11894-020-00792-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
77 Gao Y, Liu H, Tang F, Zhang X, Li F, Ye Q, Yuan H, Lv H, Han T. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis. Clin Res Hepatol Gastroenterol 2021;45:101649. [PMID: 33601064 DOI: 10.1016/j.clinre.2021.101649] [Reference Citation Analysis]
78 Qi X, Han G, Fan D. The preferable treatment for cirrhotic portal vein thrombosis: anticoagulation or transjugular intrahepatic portosystemic shunt? Hepatology. 2010;51:713-714. [PMID: 20104582 DOI: 10.1002/hep.23217] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
79 Hirakawa M, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Fujita N, Honda H. Clinical outcomes of symptomatic arterioportal fistulas after transcatheter arterial embolization. World J Radiol 2013;5:33-40. [PMID: 23494252 DOI: 10.4329/wjr.v5.i2.33] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
80 Janczak DT, Mimier MK, Mcbane RD, Kamath PS, Simmons BS, Bott-kitslaar DM, Lenz CJ, Vargas ER, Hodge DO, Wysokinski WE. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location. Mayo Clinic Proceedings 2018;93:40-7. [DOI: 10.1016/j.mayocp.2017.10.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 14.3] [Reference Citation Analysis]
81 Trebicka J, Strassburg CP. Etiology and Complications of Portal Vein Thrombosis. Viszeralmedizin. 2014;30:375-380. [PMID: 26288604 DOI: 10.1159/000369987] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
82 Buresi M, Hull R, Coffin CS. Venous thromboembolism in cirrhosis: a review of the literature. Can J Gastroenterol. 2012;26:905-908. [PMID: 23248793 DOI: 10.1155/2012/175849] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
83 De Stefano V, Qi X, Betti S, Rossi E. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment. Thromb Haemost 2016;115:240-9. [PMID: 26333846 DOI: 10.1160/TH15-04-0326] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 6.2] [Reference Citation Analysis]
84 Colaizzo D, Amitrano L, Guardascione MA, Tiscia GL, D'Andrea G, Longo VA, Grandone E, Margaglione M. Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation. Thromb Res 2013;132:e99-e104. [PMID: 23916380 DOI: 10.1016/j.thromres.2013.07.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
85 Riva N, Rancan E, Ageno W, Dentali F. Unmet clinical needs in the management of patients with splanchnic vein thrombosis. Intern Emerg Med 2010;5:459-61. [DOI: 10.1007/s11739-010-0473-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Muneer M, Abdelrahman H, El-Menyar A, Zarour A, Awad A, Al Dhaheri M, Al-Thani H. Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: 3 Case Reports and a Literature Review. Am J Case Rep 2016;17:241-7. [PMID: 27068354 DOI: 10.12659/ajcr.896892] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
87 Donadini MP, Dentali F, Ageno W. Splanchnic vein thrombosis: new risk factors and management. Thromb Res 2012;129 Suppl 1:S93-6. [PMID: 22682143 DOI: 10.1016/S0049-3848(12)70025-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
88 Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005;54:691-7. [PMID: 15831918 DOI: 10.1136/gut.2004.042796] [Cited by in Crossref: 351] [Cited by in F6Publishing: 282] [Article Influence: 21.9] [Reference Citation Analysis]
89 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Hematology/Oncology Clinics of North America 2011;25:1049-66. [DOI: 10.1016/j.hoc.2011.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
90 Adani GL, Baccarani U, Risaliti A, Sponza M, Gasparini D, Bresadola F, de Anna D, Bresadola V. Percutaneous Transhepatic Portography for the Treatment of Early Portal Vein Thrombosis After Surgery. Cardiovasc Intervent Radiol 2007;30:1222-6. [DOI: 10.1007/s00270-007-9056-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
91 Romero-gömez M, Gutierrez-tous R, Delgado-mije D. Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding. Gastroenterology 2002;122:2095. [DOI: 10.1053/gast.2002.34024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
92 De Stefano V, Martinelli I. Splanchnic vein thrombosis: clinical presentation, risk factors and treatment. Intern. Emerg Med. 2010;5:487-494. [PMID: 20532730 DOI: 10.1007/s11739-010-0413-6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
93 Bosch J, Abraldes JG, Albillos A, Aracil C, Bañares R, Berzigotti A, Calleja JL, de la Peña J, Escorsell A, García-pagán JC, Genescà J, Hernández-guerra M, Ripoll C, Planas R, Villanueva C. Hipertensión portal: recomendaciones para su evaluación y tratamiento. Gastroenterología y Hepatología 2012;35:421-50. [DOI: 10.1016/j.gastrohep.2012.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
94 Hegenbarth K, Fickert P, Aschauer M, Horina JH, Stauber RE, Trauner M. Successful management of acute portal vein thrombosis by low molecular weight heparin and oral anticoagulation. Am J Gastroenterol 2002;97:1567-8. [PMID: 12094892 DOI: 10.1111/j.1572-0241.2002.05750.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
95 Barbui T, Finazzi G. Myeloproliferative disease in pregnancy and other management issues. Hematology Am Soc Hematol Educ Program 2006;:246-52. [PMID: 17124068 DOI: 10.1182/asheducation-2006.1.246] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
96 Shatzel JJ, O'Donnell M, Olson SR, Kearney MR, Daughety MM, Hum J, Nguyen KP, DeLoughery TG. Venous thrombosis in unusual sites: A practical review for the hematologist. Eur J Haematol 2019;102:53-62. [PMID: 30267448 DOI: 10.1111/ejh.13177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
97 Spaander MCW, Hoekstra J, Hansen BE, Van Buuren HR, Leebeek FWG, Janssen HLA. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding. J Thromb Haemost 2013;11:452-9. [DOI: 10.1111/jth.12121] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
98 Riggio O, Ridola L, Lucidi C, Angeloni S. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig Liver Dis. 2010;42:462-467. [PMID: 20036625 DOI: 10.1016/j.dld.2009.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
99 Condat B, Vilgrain V, Asselah T, O’Toole D, Rufat P, Zappa M, Moreau R, Valla D. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology. 2003;37:1302-1308. [PMID: 12774008 DOI: 10.1053/jhep.2003.50232] [Cited by in Crossref: 139] [Cited by in F6Publishing: 97] [Article Influence: 7.7] [Reference Citation Analysis]
100 Haris M, Thachil J. Portal vein thrombosis - a primer for the general physician. Clin Med (Lond) 2017;17:212-9. [PMID: 28572222 DOI: 10.7861/clinmedicine.17-3-212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Spaander MC, Murad SD, van Buuren HR, Hansen BE, Kuipers EJ, Janssen HL. Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study. Gastrointestinal Endoscopy 2008;67:821-7. [DOI: 10.1016/j.gie.2007.08.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
102 Bai DS, Xia BL, Zhang C, Ye J, Qian JJ, Jin SJ, Jiang GQ. Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial. Int J Surg 2019;64:16-23. [PMID: 30851458 DOI: 10.1016/j.ijsu.2019.02.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
103 Salim S, Zarrouk M, Elf J, Gottsäter A, Ekberg O, Acosta S. Improved Prognosis and Low Failure Rate with Anticoagulation as First-Line Therapy in Mesenteric Venous Thrombosis. World J Surg 2018;42:3803-11. [PMID: 29777267 DOI: 10.1007/s00268-018-4667-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179-202. [PMID: 26516032 DOI: 10.1016/j.jhep.2015.07.040] [Cited by in Crossref: 291] [Cited by in F6Publishing: 182] [Article Influence: 48.5] [Reference Citation Analysis]
105 Nagaoki Y, Aikata H, Daijyo K, Teraoka Y, Shinohara F, Nakamura Y, Hatooka M, Morio K, Nakahara T, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Ochi H, Chayama K. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Hepatol Res. 2018;48:51-58. [PMID: 28342265 DOI: 10.1111/hepr.12895] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 14.0] [Reference Citation Analysis]
106 Han JH, Kim DS, Yu YD, Jung SW, Yoon YI, Jo HS. Analysis of risk factors for portal vein thrombosis after liver resection. Ann Surg Treat Res 2019;96:230-6. [PMID: 31073513 DOI: 10.4174/astr.2019.96.5.230] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
107 Bayraktar Y, Harmanci O, Büyükasik Y, Shorbagi AI, Sungur AH, Boylu CA, Gürgey A, Balkanci F. JAK2V617F mutation in patients with portal vein thrombosis. Dig Dis Sci 2008;53:2778-83. [PMID: 18343999 DOI: 10.1007/s10620-008-0225-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
108 Rodriguez-luna H, Vargas HE. Portal and Splenic Vein Thrombosis. Zakim and Boyer's Hepatology. Elsevier; 2006. pp. 905-14. [DOI: 10.1016/b978-1-4160-3258-8.50052-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
109 Kobilica N, Skalicky M, Milotič F, Flis V. Non-Cirrhotic and Non-Malignant Acute Extrahepatic Portal Vein Thrombosis (PVT): Short- and Long-Term Results. J Int Med Res 2011;39:1090-8. [DOI: 10.1177/147323001103900344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
110 Jiang GQ, Bai DS, Chen P, Xia BL, Qian JJ, Jin SJ. Predictors of portal vein system thrombosis after laparoscopic splenectomy and azygoportal disconnection: A Retrospective Cohort Study of 75 Consecutive Patients with 3-months follow-up. Int J Surg 2016;30:143-9. [PMID: 27154616 DOI: 10.1016/j.ijsu.2016.04.047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
111 Tsochatzis EA, Senzolo M, Germani G, Gatt A, Burroughs AK. Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2010;31:366-374. [PMID: 19863496 DOI: 10.1111/j.1365-2036.2009.04182.x] [Cited by in Crossref: 174] [Cited by in F6Publishing: 152] [Article Influence: 14.5] [Reference Citation Analysis]
112 Noronha Ferreira C, Seijo S, Plessier A, Silva-Junior G, Turon F, Rautou PE, Baiges A, Bureau C, Bosch J, Hernández-Gea V, Valla D, García-Pagan JC. Natural history and management of esophagogastric varices in chronic noncirrhotic, nontumoral portal vein thrombosis. Hepatology 2016;63:1640-50. [PMID: 26799606 DOI: 10.1002/hep.28466] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
113 Di Nisio M, Valeriani E, Riva N, Schulman S, Beyer-Westendorf J, Ageno W. Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation. J Thromb Haemost 2020;18:1562-8. [PMID: 32619346 DOI: 10.1111/jth.14836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
114 Plessier A, Rautou PE, Valla DC. Management of hepatic vascular diseases. J Hepatol 2012;56 Suppl 1:S25-38. [PMID: 22300463 DOI: 10.1016/S0168-8278(12)60004-X] [Cited by in Crossref: 132] [Cited by in F6Publishing: 36] [Article Influence: 14.7] [Reference Citation Analysis]
115 DeLeve LD. Vascular liver diseases. Curr Gastroenterol Rep. 2003;5:63-70. [PMID: 12530950 DOI: 10.1007/s11894-003-0011-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
116 Anthony Lizarraga W, Dalia S, Reinert SE, Schiffman FJ. Venous thrombosis in patients with chronic liver disease. Blood Coagul Fibrinolysis. 2010;21:431-435. [PMID: 20595823 DOI: 10.1097/mbc.0b013e328337b3ba] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
117 Bayraktar Y, Harmanci O. Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol. 2006;12:1165-1174. [PMID: 16534866 DOI: 10.3748/wjg.v12.i8.1165] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
118 Bittencourt PL, Couto CA, Ribeiro DD. Portal Vein Thrombosis and Budd–Chiari Syndrome. Clinics in Liver Disease 2009;13:127-44. [DOI: 10.1016/j.cld.2008.10.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
119 Giouleme O, Theocharidou E. Management of Portal Hypertension in Children With Portal Vein Thrombosis. Journal of Pediatric Gastroenterology & Nutrition 2013;57:419-25. [DOI: 10.1097/mpg.0b013e3182a1cd7f] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
120 Ravichandran P, Croome KP, Kovacs MJ, Lazo-Langner A, Hernandez-Alejandro R. Initial management of noncirrhotic splanchnic vein thrombosis: when is anticoagulation enough? Can J Gastroenterol Hepatol 2014;28:207-11. [PMID: 24729995 DOI: 10.1155/2014/353672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
121 Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A. Venous thromboembolic disease. J Natl Compr Canc Netw 2011;9:714-77. [PMID: 21715723 DOI: 10.6004/jnccn.2011.0062] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
122 Mcbane RD, Wysokinski WE. Treatment of venous thrombosis at unusual sites. Curr Treat Options Cardio Med 2008;10:136-45. [DOI: 10.1007/s11936-008-0015-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
123 Rajani R, Björnsson E, Bergquist A, Danielsson A, Gustavsson A, Grip O, Melin T, Sangfelt P, Wallerstedt S, Almer S. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther. 2010;32:1154-1162. [PMID: 21039677 DOI: 10.1111/j.1365-2036.2010.04454.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 64] [Article Influence: 8.5] [Reference Citation Analysis]
124 Ageno W, Dentali F, Squizzato A. How I treat splanchnic vein thrombosis. Blood 2014;124:3685-91. [DOI: 10.1182/blood-2014-07-551515] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
125 Hollingshead M, Burke CT, Mauro MA, Weeks SM, Dixon RG, Jaques PF. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol. 2005;16:651-661. [PMID: 15872320 DOI: 10.1097/01.rvi.0000156265.79960.86] [Cited by in Crossref: 188] [Cited by in F6Publishing: 47] [Article Influence: 11.8] [Reference Citation Analysis]
126 Maruyama H, Ishibashi H, Takahashi M, Shimada T, Kamesaki H, Yokosuka O. Prediction of the therapeutic effects of anticoagulation for recent portal vein thrombosis: A novel approach with contrast-enhanced ultrasound. Abdom Imaging. 2012;37:431-438. [PMID: 21904887 DOI: 10.1007/s00261-011-9795-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
127 Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Darwish Murad S. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood. 2008;111:4922-4929. [PMID: 18250227 DOI: 10.1182/blood-2007-11-125328] [Cited by in Crossref: 226] [Cited by in F6Publishing: 163] [Article Influence: 17.4] [Reference Citation Analysis]
128 You H, Zhao J, Huang C, Tian X, Li M, Zeng X. Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis. Front Med (Lausanne) 2021;8:630660. [PMID: 33614687 DOI: 10.3389/fmed.2021.630660] [Reference Citation Analysis]
129 Sabol TP, Molina M, Wu GY. Thrombotic Venous Diseases of the Liver. J Clin Transl Hepatol 2015;3:189-94. [PMID: 26623265 DOI: 10.14218/JCTH.2015.00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Spaander VMCW, Van Buuren HR, Janssen HLA. Review article: the management of non-cirrhotic non-malignant portal vein thrombosis and concurrent portal hypertension in adults: REVIEW: MANAGEMENT OF NON-CIRRHOTIC NON-MALIGNANT EPVT. Alimentary Pharmacology & Therapeutics 2007;26:203-9. [DOI: 10.1111/j.1365-2036.2007.03488.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
131 Martín-llahí M, Albillos A, Bañares R, Berzigotti A, García-criado MÁ, Genescà J, Hernández-gea V, Llop-herrera E, Masnou-ridaura H, Mateo J, Navascués CA, Puente Á, Romero-gutiérrez M, Simón-talero M, Téllez L, Turon F, Villanueva C, Zarrabeitia R, García-pagán JC. Enfermedades vasculares del hígado. Guías Clínicas de la Sociedad Catalana de Digestología y de la Asociación Española para el Estudio del Hígado. Gastroenterología y Hepatología 2017;40:538-80. [DOI: 10.1016/j.gastrohep.2017.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
132 Link CS, Platzbecker U, Kroschinsky F, Pannach S, Thiede C, Platzek I, Ehninger G, Schuler MK. Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis. Case Rep Oncol 2013;6:311-5. [PMID: 23898274 DOI: 10.1159/000352088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
133 Seijo S, Plessier A. Noncirrhotic nontumoral portal vein thrombosis. Clin Liver Dis (Hoboken) 2014;3:118-21. [PMID: 30992903 DOI: 10.1002/cld.336] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
134 Nevah MI, Fallon MB. Hepatic Encephalopathy, Hepatorenal Syndrome, Hepatopulmonary Syndrome, and Systemic Complications of Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1543-1555.e6. [DOI: 10.1016/b978-1-4160-6189-2.00092-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
135 Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis. 2010;42:163-170. [PMID: 19766546 DOI: 10.1016/j.dld.2009.08.003] [Cited by in Crossref: 87] [Cited by in F6Publishing: 65] [Article Influence: 7.3] [Reference Citation Analysis]
136 Goulding C, Uttenthal B, Foroni L, Duke V, Traore A, Kottaridis P, Hoffbrand AV, Patch D, McNamara C. The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis. Int J Lab Hematol. 2008;30:415-419. [PMID: 19046316 DOI: 10.1111/j.1751-553x.2007.00973.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
137 Ponziani FR, Zocco MA, Tortora A, Gasbarrini A. Is there a role for anticoagulants in portal vein thrombosis management in cirrhotic patients? Expert Opin Pharmacother. 2010;11:1479-1487. [PMID: 20446862 DOI: 10.1517/14656561003749264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
138 Kitchens CS, Weidner MH, Lottenberg R. Chronic oral anticoagulant therapy for extrahepatic visceral thrombosis is safe. J Thromb Thrombolysis 2007;23:223-8. [PMID: 17221331 DOI: 10.1007/s11239-006-9017-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
139 Quarrie R, Stawicki SP. Portal vein thrombosis: What surgeons need to know. Int J Crit Illn Inj Sci. 2018;8:73-77. [PMID: 29963409 DOI: 10.4103/ijciis.ijciis_71_17] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
140 Tan SBM, Greenslade J, Martin D, Talbot M, Loi K, Hopkins G. Portomesenteric vein thrombosis in sleeve gastrectomy: a 10-year review. Surgery for Obesity and Related Diseases 2018;14:271-5. [DOI: 10.1016/j.soard.2017.12.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
141 Orr DW, Patel RK, Lea NC, Westbrook RH, O'Grady JG, Heaton ND, Pagliuca A, Mufti GJ, Heneghan MA. The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther 2010;31:1330-6. [PMID: 20331577 DOI: 10.1111/j.1365-2036.2010.04299.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
142 Shah VH, Kamath PS. Portal Hypertension and Gastrointestinal Bleeding. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1489-1516.e5. [DOI: 10.1016/b978-1-4160-6189-2.00090-1] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
143 Ageno W, Dentali F, Donadini MP, Squizzato A. Optimal treatment duration of venous thrombosis. J Thromb Haemost 2013;11 Suppl 1:151-60. [PMID: 23809119 DOI: 10.1111/jth.12234] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
144 Dumic I, Tankosic N, Stojkovic Lalosevic M, Alempijevic T. Sport-Related Portal Vein Thrombosis: An Unusual Complication. Case Reports Hepatol 2017;2017:9324246. [PMID: 29259831 DOI: 10.1155/2017/9324246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
145 Kreuziger LB, Ageno W, Lee A. Management of incidental splanchnic vein thrombosis in cancer patients. Hematology Am Soc Hematol Educ Program 2014;2014:318-20. [PMID: 25696872 DOI: 10.1182/asheducation-2014.1.318] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
146 Fontana RJ. Prophylactic Anticoagulation in Cirrhotics: A Paradox for Prime Time? Gastroenterology 2012;143:1138-41. [DOI: 10.1053/j.gastro.2012.09.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
147 Cerini F, Gonzalez JM, Torres F, Puente Á, Casas M, Vinaixa C, Berenguer M, Ardevol A, Augustin S, Llop E. Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study. Hepatology. 2015;62:575-583. [PMID: 25773591 DOI: 10.1002/hep.27783] [Cited by in Crossref: 63] [Cited by in F6Publishing: 46] [Article Influence: 10.5] [Reference Citation Analysis]
148 Haris M, Thachil J. The problem with incidental and chronic portal vein thrombosis. European Journal of Internal Medicine 2017;39:e29-30. [DOI: 10.1016/j.ejim.2017.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
149 Riva N, Ageno W, Schulman S, Beyer-westendorf J, Duce R, Malato A, Santoro R, Poli D, Verhamme P, Martinelli I, Kamphuisen P, Dentali F. Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry. The Lancet Haematology 2016;3:e267-75. [DOI: 10.1016/s2352-3026(16)30020-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 5.2] [Reference Citation Analysis]
150 Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, Morard I, Lasser L, Langlet P. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology. 2010;51:210-218. [PMID: 19821530 DOI: 10.1002/hep.23259] [Cited by in Crossref: 297] [Cited by in F6Publishing: 211] [Article Influence: 27.0] [Reference Citation Analysis]
151 Zhang ZH, Zhang JW, He P, Zhou Y, Sun CY. Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients. Medicine (Baltimore). 2017;96:e8256. [PMID: 29049216 DOI: 10.1097/md.0000000000008256] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
152 Harmanci O, Ersoy O, Gurgey A, Buyukasik Y, Gedikoglu G, Balkanci F, Sivri B, Bayraktar Y. The Etiologic Distribution of Thrombophilic Factors in Chronic Portal Vein Thrombosis. Journal of Clinical Gastroenterology 2007;41:521-7. [DOI: 10.1097/01.mcg.0000225635.52780.47] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
153 Kuboki S, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takayashiki T, Takano S, Okamura D, Suzuki D, Sakai N, Kagawa S, Miyazaki M. Incidence, risk factors, and management options for portal vein thrombosis after hepatectomy: a 14-year, single-center experience. Am J Surg 2015;210:878-85.e2. [PMID: 26307424 DOI: 10.1016/j.amjsurg.2014.11.021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
154 Condat B. Thrombose de la veine porte. Gastroentérologie Clinique et Biologique 2006;30:1170-6. [DOI: 10.1016/s0399-8320(06)73496-0] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
155 Cheng Q, Tree K. Systematic Review of Thrombolysis Therapy in the Management of Non-Cirrhosis-Related Portal Vein Thrombosis. J Gastrointest Surg 2021;25:1579-90. [PMID: 33452971 DOI: 10.1007/s11605-020-04624-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30:881-894. [PMID: 19678814 DOI: 10.1111/j.1365-2036.2009.04116.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
157 Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol. 2006;101:83-90. [PMID: 16405538 DOI: 10.1111/j.1572-0241.2006.00353.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
158 Handa P, Crowther M, Douketis JD. Portal vein thrombosis: a clinician-oriented and practical review. Clin Appl Thromb Hemost. 2014;20:498-506. [PMID: 23364162 DOI: 10.1177/1076029612473515] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
159 Hirmerova J, Liska V, Mirka H, Chudacek Z, Treska V. Portal and mesenteric vein thromboses in a patient with prothrombin G20210 mutation, elevated lipoprotein (a), and high factor VIII. Clin Appl Thromb Hemost 2008;14:481-5. [PMID: 18160613 DOI: 10.1177/1076029607308392] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
160 Dupuychaffray JP, Liebaert MP, Baste JC, Desgranges P, Cherqui D, Mavier P. [Cryptogenic cirrhosis and membranous obstruction of the retrohepatic inferior vena cava]. Gastroenterol Clin Biol. 2004;28:920-921. [PMID: 15523234 DOI: 10.1016/S0399-8320(04)95161-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
161 Hrstic I, Kalauz M, Cukovic-cavka S, Ostojic R, Banfic L, Vucelic B. Treatment of extensive subacute portal, mesenteric and ileocolic vein thrombosis with recombinant tissue plasminogen activator. Blood Coagulation & Fibrinolysis 2007;18:581-3. [DOI: 10.1097/mbc.0b013e328285d822] [Cited by in Crossref: 7] [Article Influence: 0.5] [Reference Citation Analysis]
162 Gonzalez F, Condat B, Deltenre P, Mathurin P, Paris J, Dharancy S. Extensive portal vein thrombosis related to abdominal trauma. Gastroentérologie Clinique et Biologique 2006;30:314-6. [DOI: 10.1016/s0399-8320(06)73173-6] [Cited by in Crossref: 8] [Article Influence: 0.5] [Reference Citation Analysis]
163 Ertuğrul I, Köklü S, Başar O, Yüksel O, Uçar E, Coban S, Ibiş M, Arhan M, Odemiş B, Saşmaz N. Thrombosis of the portal venous system: a prospective study. J Clin Gastroenterol 2008;42:835-8. [PMID: 18469722 DOI: 10.1097/MCG.0b013e318046eadc] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
164 Easler J, Muddana V, Furlan A, Dasyam A, Vipperla K, Slivka A, Whitcomb DC, Papachristou GI, Yadav D. Portosplenomesenteric venous thrombosis in patients with acute pancreatitis is associated with pancreatic necrosis and usually has a benign course. Clin Gastroenterol Hepatol. 2014;12:854-862. [PMID: 24161350 DOI: 10.1016/j.cgh.2013.09.068] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
165 Llop E, Seijo S. [Treatment of non-cirrhotic, non-tumoural portal vein thrombosis]. Gastroenterol Hepatol 2016;39:403-10. [PMID: 26547613 DOI: 10.1016/j.gastrohep.2015.09.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
166 Riva N, Ageno W. Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions. J Clin Med 2020;9:E743. [PMID: 32164214 DOI: 10.3390/jcm9030743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
167 Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. [PMID: 17697371 DOI: 10.1186/1471-230x-7-34] [Cited by in Crossref: 108] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
168 Chandra S, Dutta U, Das R, Vaiphei K, Nagi B, Singh K. Mesenteric venous thrombosis causing jejunal stricture: secondary to hypercoagulable states and primary portal hypertension. Dig Dis Sci 2002;47:2017-9. [PMID: 12353848 DOI: 10.1023/a:1019664627149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
169 Hicks AM, DeRosa A, Raj M, Do R, Yu KH, Lowery MA, Varghese A, O'Reilly EM. Visceral Thromboses in Pancreas Adenocarcinoma: Systematic Review. Clin Colorectal Cancer 2018;17:e207-16. [PMID: 29306522 DOI: 10.1016/j.clcc.2017.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
170 Garcia-tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding-Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology 2008;47:1764-72. [DOI: 10.1002/hep.22273] [Cited by in Crossref: 180] [Cited by in F6Publishing: 135] [Article Influence: 13.8] [Reference Citation Analysis]
171 Rajesh S, Mukund A, Arora A. Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterol Res Pract 2015;2015:101029. [PMID: 26600801 DOI: 10.1155/2015/101029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
172 Magaz M, Alvarez-Larrán A, Colomer D, López-Guerra M, García-Criado MÁ, Mezzano G, Belmonte E, Olivas P, Soy G, Cervantes F, Darnell A, Ferrusquía-Acosta J, Baiges A, Turon F, Hernández-Gea V, García-Pagán JC. Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis. J Hepatol 2021;74:89-95. [PMID: 32679300 DOI: 10.1016/j.jhep.2020.06.045] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
173 Strauss E, Valla D. Non-cirrhotic portal hypertension--concept, diagnosis and clinical management. Clin Res Hepatol Gastroenterol 2014;38:564-9. [PMID: 24581591 DOI: 10.1016/j.clinre.2013.12.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
174 Alvarez-Larrán A, García-Pagán JC, Abraldes JG, Arellano E, Reverter JC, Bosch J, Cervantes F. Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera. Br J Haematol. 2004;124:329-335. [PMID: 14717780 DOI: 10.1046/j.1365-2141.2003.04770.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
175 Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16:143-155. [PMID: 20066733 DOI: 10.3748/wjg.v16.i2.143] [Cited by in CrossRef: 143] [Cited by in F6Publishing: 102] [Article Influence: 13.0] [Reference Citation Analysis]
176 Han J, Kong S, Shin C, Min S, Min S, Kim TH, Yang J, Oh S, Suh Y, Lee H, Yang H. Portomesenteric vein thrombosis after gastric surgery. Gastric Cancer 2016;19:1135-43. [DOI: 10.1007/s10120-015-0562-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
177 Hoseinzadeh S, Shafiei B, Salehian M, Neshandar Asli I, Ghodoosi I. Huge Varicose Inferior Mesenteric Vein: an Unanticipated (99m) Tc-labeled Red Blood Cell Scintigraphy Finding. Nucl Med Mol Imaging 2010;44:217-22. [PMID: 24899953 DOI: 10.1007/s13139-010-0033-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
178 Noh KW, Wolfsen HC, Bridges MD, Hinder RA. Mesenteric Venous Thrombosis Following Laparoscopic Antireflux Surgery. Dig Dis Sci 2007;52:273-5. [DOI: 10.1007/s10620-006-9290-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
179 Schultheiß M, Bettinger D, Thimme R. Nonsurgical Therapeutic Options in Portal Vein Thrombosis. Viszeralmedizin 2014;30:388-92. [PMID: 26288606 DOI: 10.1159/000369848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
180 Intagliata NM, Caldwell SH, Tripodi A. Diagnosis, Development, and Treatment of Portal Vein Thrombosis in Patients With and Without Cirrhosis. Gastroenterology 2019; 156: 1582-1599. e1. [PMID: 30771355 DOI: 10.1053/j.gastro.2019.01.265] [Cited by in Crossref: 79] [Cited by in F6Publishing: 56] [Article Influence: 39.5] [Reference Citation Analysis]
181 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 28.0] [Reference Citation Analysis]
182 Gangat N, Wolanskyj AP, Tefferi A. Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications. Eur J Haematol 2006;77:327-33. [PMID: 16856928 DOI: 10.1111/j.1600-0609.2006.00715.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
183 Jiang G, Xia B, Chen P, Qian J, Jin S, Zuo S, Bai D. Anticoagulation Therapy with Warfarin Versus Low-Dose Aspirin Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016;26:517-23. [DOI: 10.1089/lap.2016.0012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
184 Brisse H, Orbach D, Lassau N, Servois V, Doz F, Debray D, Helfre S, Hartmann O, Neuenschwander S. Portal vein thrombosis during antineoplastic chemotherapy in children: Report of five cases and review of the literature. European Journal of Cancer 2004;40:2659-66. [DOI: 10.1016/j.ejca.2004.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
185 Valla DC. Thrombosis and anticoagulation in liver disease. Hepatology 2008;47:1384-93. [DOI: 10.1002/hep.22192] [Cited by in Crossref: 77] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
186 Cohen O, Caiano LM, Tufano A, Ageno W. Cancer-Associated Splanchnic Vein Thrombosis. Semin Thromb Hemost 2021. [PMID: 34116580 DOI: 10.1055/s-0040-1722607] [Reference Citation Analysis]
187 Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol. 2013;108:568-574. [PMID: 23381015 DOI: 10.1038/ajg.2012.452] [Cited by in Crossref: 121] [Cited by in F6Publishing: 98] [Article Influence: 15.1] [Reference Citation Analysis]
188 Gerwing M, Wilms C, Heinzow H, Sporns PB, Heindel W, Schmidt H, Wildgruber M, Köhler M. Escalating interventional recanalization therapy in non-cirrhotic, non-malignant acute portal vein thrombosis. Eur J Gastroenterol Hepatol 2019;31:1584-91. [PMID: 31584464 DOI: 10.1097/MEG.0000000000001559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
189 Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012;32:919-927. [PMID: 22435854 DOI: 10.1111/j.1478-3231.2012.02785.x] [Cited by in Crossref: 210] [Cited by in F6Publishing: 167] [Article Influence: 23.3] [Reference Citation Analysis]
190 Michiels JJ, Commandeur S, Hoogenboom GJ, Wegman JJ, Scholten L, van Rijssel RH, De Raeve H. JAK2(V617F) positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature. Ann Hematol. 2007;86:793-800. [PMID: 17687555 DOI: 10.1007/s00277-007-0351-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
191 Valla D. The diagnosis and management of the Budd-Chiari syndrome: Consensus and controversies. Hepatology 2003;38:793-803. [DOI: 10.1002/hep.1840380404] [Cited by in Crossref: 142] [Cited by in F6Publishing: 68] [Article Influence: 7.9] [Reference Citation Analysis]
192 Bissonnette J, Rautou PE, Valla DC. [Idiopathic non-cirrhotic portal hypertension: An update]. Presse Med 2015;44:1009-15. [PMID: 26362514 DOI: 10.1016/j.lpm.2015.06.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
193 Galante A, De Gottardi A. Portal vein thrombosis: an overview of current treatment options. Acta Gastroenterol Belg 2021;84:327-32. [PMID: 34217184 DOI: 10.51821/84.2.327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Annibali O, Napolitano M, Avvisati G, Siragusa S. Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature. Crit Rev Oncol Hematol 2018;124:41-50. [PMID: 29548485 DOI: 10.1016/j.critrevonc.2018.02.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
195 Russell MC. Complications following hepatectomy. Surg Oncol Clin N Am. 2015;24:73-96. [PMID: 25444470 DOI: 10.1016/j.soc.2014.09.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
196 Harmanci O, Buyukasik Y, Kirazli S, Balkanci F, Bayraktar Y. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol 2006;12:1273-7. [PMID: 16534884 DOI: 10.3748/wjg.v12.i8.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
197 Jiang G, Bai D, Chen P, Qian J, Jin S, Wang X. Risk Factors for Portal Vein System Thrombosis After Laparoscopic Splenectomy in Cirrhotic Patients with Hypersplenism. Journal of Laparoendoscopic & Advanced Surgical Techniques 2016;26:419-23. [DOI: 10.1089/lap.2015.0481] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
198 Kojima S, Watanabe N, Koizumi J, Kokubu S, Murashima N, Matsutani S, Obara K. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension: Current status of portal vein thrombosis in Japan. Hepatol Res 2018;48:244-54. [DOI: 10.1111/hepr.12983] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
199 Louvet A, Texier F, Dharancy S, Pruvot FR, Sergent G, Deltenre P, Ernst O, Paris JC, Mathurin P. Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis. Dig Dis Sci 2006;51:11-7. [PMID: 16416202 DOI: 10.1007/s10620-006-3075-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
200 Raffa S, Reverter JC, Seijo S, Tassies D, Abraldes JG, Bosch J, García–pagán JC. Hypercoagulability in Patients With Chronic Noncirrhotic Portal Vein Thrombosis. Clinical Gastroenterology and Hepatology 2012;10:72-8. [DOI: 10.1016/j.cgh.2011.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
201 Condat B, Valla D. Nonmalignant portal vein thrombosis in adults. Nat Rev Gastroenterol Hepatol 2006;3:505-15. [DOI: 10.1038/ncpgasthep0577] [Cited by in Crossref: 76] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
202 Riva N, Ageno W, Poli D, Testa S, Rupoli S, Santoro R, Lerede T, Piana A, Carpenedo M, Nicolini A, Ferrini PM, Martini G, Mangione C, Contino L, Bonfanti C, Gresele P, Tosetto A. Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study. Gastroenterol Res Pract 2015;2015:620217. [PMID: 26508913 DOI: 10.1155/2015/620217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
203 DeLeve LD, Valla DC, Garcia-Tsao G;  American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764. [PMID: 19399912 DOI: 10.1002/hep.22772] [Cited by in Crossref: 599] [Cited by in F6Publishing: 411] [Article Influence: 49.9] [Reference Citation Analysis]
204 Frutos Bernal M, Fernández Hernández J, Carrasco Prats M, Soria Cogollos T, Luján Mompeán J, Hernández Agüera Q, Parrilla Paricio P. Trombosis venosa portoesplenomesaraica secundaria a mutación del gen de la protrombina. Gastroenterología y Hepatología 2005;28:329-32. [DOI: 10.1157/13076350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
205 Sekhar M, McVinnie K, Burroughs AK. Splanchnic vein thrombosis in myeloproliferative neoplasms. Br J Haematol 2013;162:730-47. [PMID: 23855810 DOI: 10.1111/bjh.12461] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
206 Ageno W, Beyer-Westendorf J, Garcia DA, Lazo-Langner A, McBane RD, Paciaroni M. Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis 2016;41:129-43. [PMID: 26780742 DOI: 10.1007/s11239-015-1308-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 9.4] [Reference Citation Analysis]
207 Sogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol. 2007;7:34. [PMID: 17697371 DOI: 10.1186/1471-230x-7-34/] [Reference Citation Analysis]
208 Barrault C, Plessier A, Valla D, Condat B. [Non surgical treatment of Budd-Chiari syndrome: a review]. Gastroenterol Clin Biol 2004;28:40-9. [PMID: 15041809 DOI: 10.1016/s0399-8320(04)94839-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
209 van Es N, Bleker SM, Wilts IT, Porreca E, Di Nisio M. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy. Drugs 2016;76:331-41. [DOI: 10.1007/s40265-015-0526-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
210 Yonal I, Pinarbası B, Hindilerden F, Hancer VS, Nalcaci M, Kaymakoglu S, Diz-Kucukkaya R. The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. J Thromb Thrombolysis 2012;34:388-96. [PMID: 22569900 DOI: 10.1007/s11239-012-0738-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
211 Tuite DJ, Rehman J, Davies MH, Patel JV, Nicholson AA, Kessel DO. Percutaneous Transsplenic Access in the Management of Bleeding Varices from Chronic Portal Vein Thrombosis. Journal of Vascular and Interventional Radiology 2007;18:1571-5. [DOI: 10.1016/j.jvir.2007.08.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
212 Sacerdoti D, Serianni G, Gaiani S, Bolognesi M, Bombonato G, Gatta A. Thrombosis of the portal venous system. J Ultrasound 2007;10:12-21. [PMID: 23396402 DOI: 10.1016/j.jus.2007.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
213 Poreddy V, Deleve LD. Hepatic circulatory diseases associated with chronic myeloid disorders. Clinics in Liver Disease 2002;6:909-31. [DOI: 10.1016/s1089-3261(02)00051-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
214 Webster GJ, Burroughs AK, Riordan SM. Review article: portal vein thrombosis -- new insights into aetiology and management. Aliment Pharmacol Ther. 2005;21:1-9. [PMID: 15644039 DOI: 10.1111/j.1365-2036.2004.02301.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 88] [Article Influence: 6.3] [Reference Citation Analysis]
215 Vietti Violi N, Fournier N, Duran R, Schmidt S, Bize P, Guiu B, Denys A. Acute Mesenteric Vein Thrombosis: Factors Associated With Evolution to Chronic Mesenteric Vein Thrombosis. American Journal of Roentgenology 2014;203:54-61. [DOI: 10.2214/ajr.13.11527] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
216 Hibi A, Mogi K. Portal vein thrombosis after cesarean section in a patient on prolonged bed rest due to threatened preterm labor. Clin Case Rep 2018;6:531-6. [PMID: 29531735 DOI: 10.1002/ccr3.1405] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
217 Dell’era A, Seijo S. Portal vein thrombosis in cirrhotic and non cirrhotic patients: from diagnosis to treatment. Expert Opinion on Orphan Drugs 2016;4:927-40. [DOI: 10.1080/21678707.2016.1215907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
218 Sarin SK, Gupta N, Jha SK, Agrawal A, Mishra SR, Sharma BC, Kumar A. Equal efficacy of endoscopic variceal ligation and propranolol in preventing variceal bleeding in patients with noncirrhotic portal hypertension. Gastroenterology. 2010;139:1238-1245. [PMID: 20547163 DOI: 10.1053/j.gastro.2010.06.017] [Cited by in Crossref: 58] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
219 Sofia C, Cattafi A, Silipigni S, Pitrone P, Carerj ML, Marino MA, Pitrone A, Ascenti G. Portal vein thrombosis in patients with chronic liver diseases: From conventional to quantitative imaging. Eur J Radiol 2021;142:109859. [PMID: 34284232 DOI: 10.1016/j.ejrad.2021.109859] [Reference Citation Analysis]
220 Moerkercke WV, Pauwelyn K, Brugman E, Verhamme M. Cytomegalovirus-associated superior mesenteric vein thrombosis treated with systemic and in-situ thrombolysis: . European Journal of Gastroenterology & Hepatology 2009;21:587-92. [DOI: 10.1097/meg.0b013e3283196b15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
221 Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5:22-40. [PMID: 25941431 DOI: 10.1016/j.jceh.2014.12.008] [Cited by in Crossref: 82] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
222 Naymagon L, Tremblay D, Schiano T, Mascarenhas J. The role of anticoagulation in pylephlebitis: a retrospective examination of characteristics and outcomes. J Thromb Thrombolysis 2020;49:325-31. [PMID: 31493290 DOI: 10.1007/s11239-019-01949-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
223 Amitrano L, Guardascione MA. Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis. 2009;1:e2009014. [PMID: 21415954 DOI: 10.4084/mjhid.2009.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
224 Stefano VD, Fiorini A, Rossi E, Za T, Chiusolo P, Sica S, Leone G. High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis. Hepatology 2007;45:831-2. [DOI: 10.1002/hep.21601] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
225 Vilgrain V, Condat B, O’Toole D, Plessier A, Ruszniewski P, Valla DC. Pancreatic portal cavernoma in patients with cavernous transformation of the portal vein: MR findings. Eur Radiol. 2009;19:2608-2613. [PMID: 19471939 DOI: 10.1007/s00330-009-1459-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
226 Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, Nagao Y, Hashimoto N, Uehara H, Tomikawa M, Shirabe K, Maehara Y. Portal vein thrombosis in liver cirrhosis. World J Hepatol. 2014;6:64-71. [PMID: 24575165 DOI: 10.4254/wjh.v6.i2.64] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
227 Amitrano L, Guardascione MA, Menchise A, Martino R, Scaglione M, Giovine S, Romano L, Balzano A. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2010;44:448-451. [PMID: 19730112 DOI: 10.1097/mcg.0b013e3181b3ab44] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 5.5] [Reference Citation Analysis]
228 Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterology 2002;97:535-41. [DOI: 10.1111/j.1572-0241.2002.05527.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 84] [Article Influence: 5.6] [Reference Citation Analysis]
229 Henry Z, Uppal D, Saad W, Caldwell S. Gastric and Ectopic Varices. Clinics in Liver Disease 2014;18:371-88. [DOI: 10.1016/j.cld.2014.01.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
230 Bittencourt PL, Farias AQ, Strauss E, Mattos AA; Pannel of the 1st Brazilian Consensus of Variceal Bleeding, Brazilian Society of Hepatology. Variceal bleeding: consensus meeting report from the Brazilian Society of Hepatology. Arq Gastroenterol. 2010;47:202-216. [PMID: 20721469 DOI: 10.1590/s0004-28032010000200017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
231 Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol 2019;71:175-99. [PMID: 30822449 DOI: 10.1016/j.jhep.2019.02.015] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 15.5] [Reference Citation Analysis]
232 Rodriguez-Luna H, Vargas HE. Portal vein thrombosis. Curr Treat Options Gastroenterol 2007;10:435-43. [PMID: 18221604 DOI: 10.1007/s11938-007-0043-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
233 Kori I, Bar-Zohar D, Carmiel-Haggai M, Samuels D, Nakache R, Oren R, Kessler A, Szold O, Ben-Haim M. Budd-Chiari syndrome and acute portal vein thrombosis: management by a transjugular intrahepatic portosystemic shunt (TIPS) and portal vein interventions via a TIPS. J Gastrointest Surg 2006;10:417-21. [PMID: 16504889 DOI: 10.1016/j.gassur.2005.07.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
234 Søgaard KK, Adelborg K, Darvalics B, Horváth-Puhó E, Beyer-Westendorf J, Ageno W, Sørensen HT. Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study. Lancet Haematol 2018;5:e441-9. [PMID: 30201587 DOI: 10.1016/S2352-3026(18)30133-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
235 Rodrigues SG, Sixt S, Abraldes JG, De Gottardi A, Klinger C, Bosch J, Baumgartner I, Berzigotti A. Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis. Aliment Pharmacol Ther. 2019;49:20-30. [PMID: 30450634 DOI: 10.1111/apt.15044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
236 Fraser CJ, Newall F, Furmedge J, Campbell J, Savoia H, Monagle PT. Acute idiopathic portal vein thrombosis in a child: a case report and literature review. Thromb Res 2006;117:279-81. [PMID: 16378832 DOI: 10.1016/j.thromres.2005.02.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
237 Janssen HLA, Leebeek FWG. JAK2 mutation: The best diagnostic tool for myeloproliferative disease in splanchnic vein thrombosis? Hepatology 2006;44:1391-3. [DOI: 10.1002/hep.21489] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
238 Lai L, Brugge WR. Endoscopic ultrasound is a sensitive and specific test to diagnose portal venous system thrombosis (PVST). Am J Gastroenterol. 2004;99:40-44. [PMID: 14687139 DOI: 10.1046/j.1572-0241.2003.04020.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
239 Qi X, Ren W, De Stefano V, Fan D. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:1801-12.e7. [PMID: 24793031 DOI: 10.1016/j.cgh.2014.04.026] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
240 Huard G, Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol. 2012;2012:672986. [PMID: 22778970 DOI: 10.1155/2012/672986] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
241 Hall TC, Garcea G, Metcalfe M, Bilku D, Dennison AR. Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review. World J Surg. 2011;35:2510-2520. [PMID: 21882035 DOI: 10.1007/s00268-011-1198-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 53] [Article Influence: 9.6] [Reference Citation Analysis]
242 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis. 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
243 Cao MT, Higuchi R, Yazawa T, Uemura S, Izumo W, Matsunaga Y, Sato Y, Morita S, Furukawa T, Egawa H, Yamamoto M. Narrowing of the remnant portal vein diameter and decreased portal vein angle are risk factors for portal vein thrombosis after perihilar cholangiocarcinoma surgery. Langenbecks Arch Surg 2021;406:1511-9. [PMID: 33409580 DOI: 10.1007/s00423-020-02044-1] [Reference Citation Analysis]
244 Riva N, Dentali F, Donadini MP, Squizzato A, Ageno W. Risk of recurrence of unusual site venous thromboembolism. Hamostaseologie 2017;33:225-31. [DOI: 10.5482/hamo-13-03-0006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
245 Senzolo M, Patch D, Miotto D, Ferronato C, Cholongitas E, Burroughs AK. Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis. Hepatology 2008;48:1352-3. [DOI: 10.1002/hep.22503] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
246 Parikh S, Shah R, Kapoor P. Portal vein thrombosis. Am J Med. 2010;123:111-119. [PMID: 20103016 DOI: 10.1016/j.amjmed.2009.05.023] [Cited by in Crossref: 108] [Cited by in F6Publishing: 75] [Article Influence: 9.8] [Reference Citation Analysis]
247 Hoekstra J, Bresser EL, Smalberg JH, Spaander MCW, Leebeek FWG, Janssen HLA. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms: Portal vein thrombosis and myeloproliferative neoplasms. Journal of Thrombosis and Haemostasis 2011;9:2208-14. [DOI: 10.1111/j.1538-7836.2011.04484.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
248 Ball CG, MacLean AR, Buie WD, Smith DF, Raber EL. Portal vein thrombi after ileal pouch-anal anastomosis: its incidence and association with pouchitis. Surg Today. 2007;37:552-557. [PMID: 17593473 DOI: 10.1007/s00595-006-3470-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
249 Harmanci O, Bayraktar Y. Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol. 2007;13:2535-2540. [PMID: 17552000 DOI: 10.3748/wjg.v13.i18.2535] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
250 Senzolo M, Ferronato C, Burra P, Sartori MT. Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med. 2009;4:161-162; author reply 163-164. [PMID: 19130177 DOI: 10.1007/s11739-008-0219-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
251 Martinez JP, Hogan GJ. Mesenteric ischemia. Emergency Medicine Clinics of North America 2004;22:909-28. [DOI: 10.1016/j.emc.2004.05.002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
252 Seijo-ríos S, García-pagán JC. Trombosis portal. Gastroenterología y Hepatología 2010;33:179-90. [DOI: 10.1016/j.gastrohep.2009.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]